Credit Agricole’s Teva Pharmaceuticals TEVA Stock Holding History

Credit Agricole’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-243,500	Closed	-$8.83M	–	1690
2016 Q4	$8.83M	Hold	243,500	–	–	0.03%	530
2016 Q3	$11.2M	Buy	243,500 +35,000	+17%	+$1.83M	0.04%	450
2016 Q2	$10.5M	Hold	208,500	–	–	0.04%	421
2016 Q1	$11.2M	Buy	208,500 +118,700	+132%	+$6.96M	0.05%	362
2015 Q4	$5.89M	Hold	89,800	–	–	0.03%	515
2015 Q3	$5.07M	Sell	89,800 -330,200	-79%	-$21.4M	0.03%	556
2015 Q2	$24.8M	Hold	420,000	–	–	0.12%	196
2015 Q1	$26.2M	Buy	420,000 +140,000	+50%	+$8.14M	0.12%	195
2014 Q4	$16M	Buy	280,000 +140,000	+100%	+$7.8M	0.07%	322
2014 Q3	$7.53M	Hold	140,000	–	–	0.03%	501
2014 Q2	$7.34M	Buy	+140,000	New	+$7.16M	0.03%	524

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole's TEVA Position: Q1 2026 in Review

Credit Agricole reduced its Teva Pharmaceuticals (TEVA) stake by 5.9% in Q1 2026, selling an estimated $48.6K and leaving 23,956 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Credit Agricole first reported a position in TEVA in Q1 2014 and has held it in 44 quarters since. The position peaked at $67M in Q4 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Credit Agricole held 23,956 shares of Teva Pharmaceuticals worth $722K as of Q1 2026.
Credit Agricole sold 1,512 Teva Pharmaceuticals shares in Q1 2026, an estimated $48.6K.
Teva Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1136 holding.
Credit Agricole first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 44 quarters since.
Credit Agricole's Teva Pharmaceuticals position peaked at $67M in Q4 2015.
651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.